Thymic Health Tied to Cancer Risk and Treatment Responses.

A deep-learning model applied to chest CT scans reveals that variation in thymus health tracks with both cancer susceptibility and clinical response after treatment with checkpoint inhibitors. The findings point to routine imaging data as a scalable approach to risk assessment and therapy selection, and highlight the underappreciated role of thymic function in shaping cancer outcomes.